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Abstract
Introduction Continuous renal replacement therapy (CRRT)
frequently gives rise to complications in critically ill children.
However, no studies have analyzed these complications
prospectively. The purpose of this study was to analyze the
complications of CRRT in children and to study the associated
risk factors.
Methods A prospective, single-centre, observational study was
performed in all critically ill children treated using CRRT in order
to determine the incidence of complications related to the
technique (problems of catheterization, hypotension at the time
of connection to the CRRT, hemorrhage, electrolyte
disturbances) and their relationship with patient characteristics,
clinical severity, need for vasoactive drugs and mechanical
ventilation, and the characteristics of the filtration techniques.
Results Of 174 children treated with CRRT, 13 (7.4%)
presented problems of venous catheterization; this complication
was significantly more common in children under 12 months of
age and in those weighing less than 10 kg. Hypotension on
connection to CRRT was detected in 53 patients (30.4%).
Hypotension was not associated with any patient or CRRT
characteristics. Clinically significant hemorrhage occurred in 18
patients (10.3%); this complication was not related to any of the
variables studied. The sodium, chloride, and phosphate levels
fell during the first 72 hours of CRRT; the changes in electrolyte
levels during the course of treatment were not found to be
related to any of the variables analyzed, nor were they
associated with mortality.
Conclusions CRRT-related complications are common in
children and some are potentially serious. The most common are
hypotension at the time of connection and electrolyte
disturbances. Strict control and continuous monitoring of the
technique are therefore necessary in children on CRRT.
Introduction
Continuous renal replacement therapy (CRRT) is currently the
most widely used technique for extrarenal filtration in critically
ill children, because it allows continuous and programmed
fluid removal [1-5].
Although a number of studies have demonstrated that these
techniques are useful and safe in critically ill children of any
age [4-7], complications do occur [8]. Children are at a higher
risk than adults for developing complications associated with
CRRT due to the difficulty of venous catheterization with the
large-caliber catheters required for the technique, the large
extracorporeal volume of the system (filters and lines), which
predisposes to hypotension at the time of connection, and the
need for a more accurate control of volumes in order to avoid
fluid and electrolyte disturbances.
There are no studies that have prospectively analyzed the
complications or risk factors in children on CRRT.
ALT: alanine transferase; CRRT: continuous renal replacement therapy; MBP: mean blood pressure; PELOD score: paediatric logistic organ dysfunc-
tion score; PIM score: pediatric index of mortality score; PRISM score: pediatric risk of mortality score.Critical Care    Vol 13 No 6    Santiago et al.
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The objective of the present study was to determine the inci-
dence of complications in children requiring CRRT and to ana-
lyze the predisposing risk factors.
Materials and methods
An analysis was performed of the data from a prospective, sin-
gle-center register of critically ill children treated using CRRT.
The study was approved by the local Institutional Review
Board and due to the characteristics of the study inform con-
sent of patients was not considered to be necessary. Between
January 1996 and June 2009, CRRT techniques were used in
174 children (105 boys (60.3%) and 69 girls (39.7%)) with a
mean (standard deviation) age of 52.3 (63.8) months and
weight of 17.6 (18.2) kg; 43.7% of the patients were under
one year of age. The most common conditions in patients
requiring CRRT were heart disease (55.7%), particularly dur-
ing the postoperative period of cardiac surgery, and sepsis
(19.5%).
Two different renal replacement pumps were used to perform
CRRT: the BSM321C (Hospal®, Barcelona, Spain) in the first
35 patients and the Prisma (Hospal®, Barcelona, Spain) in the
remaining 139. The caliber of the catheters used was between
4F and 11F and the filters were between 0.04 m2 and 0.9 m2,
according to the age and weight of the patient. All patients
received continuous anticoagulation with heparin to maintain
an activated coagulation time between 130 and 200 seconds.
Other anticoagulant or antiaggregant drugs (citrate, warfarin,
aspirin, prostacyclin) were not administered.
The following data were gathered prospectively in all patients
on starting CRRT: age; weight; sex; diagnosis; severity scores,
pediatric risk of mortality (PRISM II) score [9], pediatric index
of mortality (PIM I and II) score [10], pediatric logistic organ
dysfunction (PELOD) score only from 2001 [11]; number of
organ failures; blood pressure; need for vasoactive drugs;
dose of dopamine and adrenaline; lactic acid levels; pH and
base excess; levels of creatinine, urea, alanine transaminase
(ALT), bilirubin, sodium, potassium, chloride, calcium, phos-
phorus, magnesium, albumin and platelets; and type of filtra-
tion pump used. The type of connection to CRRT was
determined by the physician responsible for the patient. In
some cases the connection was made directly to the circuit
that had previously been primed using normal saline, in others,
after purging with heparin, the system was flushed using 5%
albumin before connection to the patient. During filtration, a
daily record was kept of the technique used (hemodiafiltration
or hemofiltration), maximum dose of heparin, ultrafiltration rate,
life of each filter, electrolyte levels, complications related to the
CRRT, and mortality during admission to the pediatric inten-
sive care unit.
The following complications were analyzed: 1) complications
of catheterization, defined as hemorrhage with a fall of more
than 2 g/dL in the hemoglobin concentration and/or hypoten-
sion or the need for transfusion and/or withdrawal of the cath-
eter from that site, thrombosis, pneumothorax, and altered limb
perfusion; 2) hypotension on connection to the filter, defined
as a fall in the mean blood pressure (MBP) of more than 20
mmHg over baseline and/or an MBP more than two standard
deviations below the normal values for age and that required
volume expansion and/or an increase in the dose of vasoactive
drugs that the patient was receiving in the first 60 minutes
after the connection to CRRT; 3) significant hemorrhage,
defined as a fall of more than 2 g/dL in the hemoglobin con-
centration in the first 24 hours after bleeding and/or hypoten-
sion and that required packed red cell transfusion; and 4)
electrolyte disturbances including hyponatremia (sodium
<130 mEq/L), hypernatremia (sodium >150 mEq/L), hypoka-
lemia (potassium <3 mEq/L), hyperkalemia (potassium >5.5
mEq/L), hypochloremia (chlorine <95 mEq/L), hyperchloremia
(chlorine >115 mEq/L), hypocalcemia (total calcium <8 mg/
dL), hypercalcemia (total calcium >12 mg/dL), hypophos-
phatemia (phosphate <4 mg/dL in children <6 years and
phosphate <3 mg/dL in children >6 years), hyperphos-
phatemia (phosphate >7 mg/dL), hypomagnesemia (magne-
sium <1.5 mg/dL), and hypermagnesemia (magnesium >3
mg/dL). An analysis was performed of the changes in the elec-
trolyte levels during the first three days of CRRT. The inci-
dence of complications of CRRT between the first seven years
and the second seven years of the study was compared.
The statistical analysis of the results was performed using the
SPSS statistical package version 14.0. Pearson's chi-squared
test and Fisher's exact test were used to compare percent-
ages and the Mann-Whitney test to compare values with a
non-parametric distribution. Significance was taken as a P
value less than 0.05.
Results
Complications of catheterization
Complications of catheterization for CRRT occurred in 13
patients (7.4%), four of whom presented more than one such
complication. The complications included hematoma at the
puncture site (6 cases, 3.4%), hemorrhage (4 cases, 2.2%),
altered venous drainage of the lower limbs (6 cases, 3.4%),
and incorrect position of the jugular venous catheter requiring
change (1 case, 0.05%). There were no cases of pneumotho-
rax or hemothorax. Patients with complications of catheteriza-
tion had a significantly lower age and weight than the other
patients, and these complications were most common in chil-
dren younger than 12 months of age and with a weight of less
than 10 kg (Table 1).
There was no relationship between the complications of cath-
eterization and the diagnosis, clinical severity of the patients at
the time of starting the technique, need for mechanical ventila-
tion, caliber of the catheter, initial platelet count (Table 1), or
venous access used (subclavian, 5%; jugular, 7.7%; femoral,
8.2%; P = 0.912).Available online http://ccforum.com/content/13/6/R184
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Table 1
Risk factors of catheterization complications in children with CRRT
With complications Without complications P
Mean SD Mean SD
Age (months) 20.2 39.4 53.6 64.2 0.016
Weight (kg) 8.0 10.4 17.9 18.4 0.014
PRISM score 14.7 8.4 14.7 8.4 0.596
PIM score -2.8 1.4 -1.9 1.4 0.181
PELOD score 23.2 3.9 17.2 8.2 0.095
Number of failed organs 2.8 1.0 2.9 1.1 0.922
Lactic acid (mmol/L) 2.1 1.2 3.1 3.7 0.725
Arterial pH 7.27 0.1 7.32 0.1 0.416
Mean blood pressure (mmHg) 53.7 27 62.0 17.9 0.173
Dose of adrenaline (μg/kg/min) 0.3 0.2 0.5 1.2 0.914
Dose of dopamine (μg/kg/min) 8.4 9.5 9.1 6.3 0.208
Initial creatinine (mg/dL) 1.3 1 1.5 1.4 0.825
Initial urea (mg/dL) 92.0 83.1 83.4 57.9 0.835
ALT (UI/L) 89.7 151.3 222.3 756.6 0.977
Billirubin (mg/dL) 1.5 1.5 1.9 2.3 0.781
Initial platelet count 158.583 124.291 175.425 188.538 0.821
Complications Number % Complications Number %
Age <12 m >12 m
10 13.2 3 3.1 0.013
Sex Male female
8 7.8 5 7.2 0.889
Weight <10 kg >10 kg
11 12.2 2 2.4 0.015
Diagnoses Cardiopathies Rest of diagnoses
5 5.3 8 10.4 0.206
Mechanical ventilation Yes No
11 7.6 2 7.4 0.974
Vasoactive drugs Yes No
10 7.4 3 8.3 0.843
Initial MAP <55 mmHg >55 mmHg
8 11.4 5 4.4 0.112Critical Care    Vol 13 No 6    Santiago et al.
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The incidence of complications of catheterization was higher
in the first period of the study 14.5% than in the second period
(4.2%; P = 0.01).
None of the complications of catheterization gave rise to seri-
ous clinical repercussions or prevented the use of CRRT.
There was no relation between the complications of catheter-
ization and mortality.
Hypotension at the time of connection to the CRRT
Before connecting to CRRT, 72 patients (41.3%) had hypo-
tension. Hypotension was more common in children with heart
disease, with greater clinical severity at the time of starting
CRRT (evaluated using the PRISM, PIM, and PELOD scores,
number of organ failures, lactic acid levels, MBP, need for
mechanical ventilation or vasoactive drugs, dose of adrenaline
and dopamine before starting CRRT, and liver function (ALT
and bilirubin). Children with previous hypotension had a signif-
icantly higher mortality than the other children.
On the other hand, hypotension soon after connecting the
CRRT occurred in 53 patients (30.4%). Hypotension on con-
nection to the CRRT was not statistically associated with any
patient or CRRT characteristics and there were no differences
in the incidence of hypotension between the two periods of
the study (Table 2).
It was not possible to determine whether priming with albumin
was associated with a need for lower volume expansion or less
increase in the dose of vasoactive drugs. We only recorded if
hypotension developed and whether or not volume expansion
or an increase in the dose of drugs was required, not the
actual volume of fluids or dose of drugs administered.
Hemorrhage
Clinically significant hemorrhage during CRRT occurred in 18
patients (10.3%). There was no relation between the presence
of hemorrhage and age, weight, diagnosis, or clinical severity
at the start of CRRT (Table 3). Although the platelet counts
were slightly lower in children with hemorrhage, the differ-
ences did not reach statistical significance at any time during
the course of treatment (Table 3). However, patients with
bleeding did receive platelet transfusions more frequently. The
maximum doses of heparin administered did not differ signifi-
cantly between patients with hemorrhage and other patients
(Table 3). Patients with hemorrhage presented a higher mor-
tality than other patients, although the differences did not
reach statistical significance (P = 0.068; Table 3).
The incidence of clinically significant hemorrhage was slightly
higher in the first period of the study (14.5%) than in the sec-
ond period (8.5%), however, the difference was not significant
(P = 0.2).
Electrolyte disturbances
The changes in the electrolyte levels (sodium, potassium, chlo-
ride, calcium, phosphorus, and magnesium) over the first 72
hours of CRRT are shown in Figures 1 and 2. In the first 72
hours of CRRT, the levels of sodium, chloride, and phosphate
fell significantly, total calcium increased significantly, and the
levels of potassium and magnesium remained unaltered. Fig-
ures 3 and 4 show the percentage of electrolyte disturbances
during the first three days of CRRT. The percentage of
patients with raised electrolyte levels decreased progressively
during the first three days of therapy (Figure 3). In contrast, the
percentage of patients with hyponatremia, hypochloremia, and
hypophosphatemia increased significantly during CRRT,
requiring an increase in the concentration of these electrolytes
in the dialysis and replacement fluids and/or intravenous sup-
plements (Figure 4). The electrolyte disturbances did not lead
to clinical manifestations except in one patient in whom Dial-
isan AFB (Hospal®, Barcelona, Spain) was used as the dialy-
sis fluid. This fluid has a sodium concentration of 4725 mEq/L
and requires dilution of 1 mL in 35 mL of water before use; in
error, the solution was used undiluted for a few hours and the
patient presented hypernatremia of 216 mEq/L, hyperchlo-
Initial hypotension Yes No
7 8.3 6 6 0.530
Dose of adrenaline > 0.6 μg/kg/min > 0.6 μg/kg/min
3 8.8 7 6.4 0.632
Catheter size 4 to 6.5 Fr >6.5 Fr
10 9.8 2 3.8 0.183
Mortality Yes No
4 30.8 9 36.5 0.680
ALT = alanine transferase; CRRT = continuous renal replacement therapy; MAP = mean arterial pressure; PELOD = pediatric logistic organ 
dysfunction; PIM = pediatric index of mortality; PRIMS = pediatric risk of mortality; SD = standard deviation.
Table 1 (Continued)
Risk factors of catheterization complications in children with CRRTAvailable online http://ccforum.com/content/13/6/R184
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Table 2
Risk factors of hypotension during connection of CRRT in children
Hypotension No hypotension P
Mean SD Mean SD
Age (months) 53.4 67.5 50.0 61.4 0.694
Weight (kg) 18.1 19.8 16.9 17.3 0.910
PRISM score 16.8 15.5 21.6 25.8 0.650
PIM score 10.1 13.4 10.9 16.8 0.874
PELOD score 25.7 30.2 20.7 22.7 0.294
Number of failed organs 3.2 1.2 2.8 1.1 0.139
Lactic acid (mmol/L) 3.2 3.3 3.0 3.8 0.357
Arterial pH 7.32 0.12 7.31 0.10 0.341
MAP (mmHg) 58.2 14.8 62.9 20.2 0.124
Dose of adrenaline (μg/kg/min) 0.4 0.5 0.57 1.3 0.734
Dose of dopamine (μg/kg/min) 9.1 6.6 9.0 6.6 0.932
Initial creatinine (mg/dL) 1.4 1.1 1.5 1.3 0.491
Initial urea (mg/dL) 79.2 61.4 86.2 59.6 0.236
ALT (UI/L) 523.5 1261.7 71.0 112.5 0.212
Billirubine (mg/dL) 1.8 1.6 1.8 2.4 0.667
Extracorporeal circuit volume/weight of patient (ml/kg) 8.6 4.6 8.8 5.3 0.982
Hypotension
Number %
Hypotension
Number %
Age <12 m >12 m
24 31.6 29 30.2 0.847
Sex Male Female
34 33 19 27.5 0.446
Weight <10 kg >10 kg
27 30 35 31.7 0.809
Diagnoses Cardiopathies Rest of diagnoses
31 32.6 22 28.6 0.566
Mechanical ventilation Yes No
48 33.1 5 18.5 0.132
Vasoactive drugs Yes No
42 30.9 11 30.6 0.970
Initial MAP <55 mmHg >55 mmHg
24 38.1 25 27.5 0.164Critical Care    Vol 13 No 6    Santiago et al.
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remia of 189 mEq/L, and ionic calcium of 4 mmol/L, leading to
hypertension and a convulsive crisis. The electrolyte distur-
bances were corrected by substitution of the dialysis fluid (by
a specific CRRT dialysis fluid) [12]; after correction, the
patient presented a good clinical course and there have been
no neurological or renal sequelae after nine years of follow-up.
The alterations in the electrolyte levels during the course of the
study were not related to any of the variables analyzed or to the
filtration technique used. There was no correlation between
mortality and any of the electrolyte disturbances during the
course of the study (data not shown).
Discussion
Our study is the first that has prospectively investigated com-
plications related to CRRT in critically ill children and that has
analyzed the factors associated with these complications.
The percentage of complications of venous catheterization
was similar to that found in other studies of central line cathe-
terization in pediatric patients, despite the fact that the cathe-
ters necessary for CRRT are larger [13-15]. The complications
of catheterization were more common in smaller children
because catheterization is more difficult in these patients and
because the caliber of the catheter used in infants is propor-
tionally larger than in older children. In contrast to other series,
we did not find differences in the rate of complications
between the use of veins in the upper body (jugular and sub-
clavian) or lower body (femoral) [13,15]. A recent study in
adults that compared jugular and femoral venous access for
acute CRRT found that the incidence of hematomas was
higher in jugular than in femoral access, with no significant dif-
ferences in the rates of infection secondary to catheterization
[16]. The incidence of catheter-related infection was not ana-
lyzed in the present study. A recent study has shown that ultra-
sound-guided central venous catheter placement decreases
the complications of catheterization, although we have not
used this method in our patients [17].
Hypotension after connection to the CRRT system was the
most common complication; it is more common in children
because the extracorporeal volume of the circuit and filter
used for CRRT represents 10 to 5% of a patient's blood vol-
ume [5]. The circuits used in our study have a priming volume
(including the filter) of 50, 100, and 130 mL depending on the
surface area of the filter used (0.04, 0.6, or 0.9 m2, respec-
tively). Although the circuit priming volume is proportionally
larger in children of lower weight, we did not find any relation
between the frequency of hypotension and age, weight, or sur-
face area of the filters. The design of filters and circuits with a
low priming volume is an essential factor in the reduction of
hemodynamic complications at the time of connection to the
system.
Patients with previous hemodynamic alterations theoretically
could have more hypotension after connection to the CRRT.
However, surprisingly in our study, we have not found any indi-
vidual factors associated with hypotension after CRRT con-
nection. It is possible that, although individually each risk factor
is not associated with hypotension, the combination of several
risk factors such as the extracorporeal volume of the circuit
and filter and the previous hemodynamic alterations could
influence the development of hypotension after connection to
CRRT.
There are a number of techniques that can be used to attempt
to reduce the risk of hypotension at the time of connection,
such as priming the circuit with whole blood or colloids,
although there are no studies that have analyzed their efficacy.
Patients on CRRT usually received many blood transfusions.
To reduce the risks of transfusion, we decided to more fre-
quently prime the circuit with 5% albumin rather than with
whole blood if the hemoglobin is not very low. However, in our
Dose of adrenaline > 0.6 μg/kg/min > 0.6 μg/kg/min
12 35.3 32 29.4 0.513
Filter surface <0.3 m2 >0.3 m2
21 33.3 32 24.4 0.586
Extracorporeal circuit volume/weight of patient > 5 ml/kg < 5 ml/kg
36 32.1 10 22.2 0.217
Mortalilty Yes No
24 38.7 29 26.4 0.095
ALT = alanine transferase; CRRT = continuous renal replacement therapy; MAP = mean arterial pressure; PELOD = pediatric logistic organ 
dysfunction; PIM = pediatric index of mortality; PRIMS = pediatric risk of mortality; SD = standard deviation.
Table 2 (Continued)
Risk factors of hypotension during connection of CRRT in childrenAvailable online http://ccforum.com/content/13/6/R184
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Table 3
Risk factors of bleeding complications in children with CRRT
Bleeding No bleeding P
Mean SD Mean SD
Age (months) 64.2 70.8 49.5 62.3 0.385
Weight (kg) 22.7 22.0 16.6 17.5 0.310
PRISM score 15.0 7.0 14.7 8.5 0.643
PIM score -2.1 0.9 -2.0 1.5 0.929
PELOD score 18.1 9.2 17.5 8.1 0.402
Number of failed organs 3.3 1.1 2.9 1.1 0.189
Lactic acid (mmol/L) 4.3 5.4 2.9 3.4 0.530
Arterial pH 7.31 0.1 7.31 0.1 0.906
MAP (mmHg) 56.2 22.7 62.0 18.2 0.211
Dose of adrenaline (μg/kg/min) 0.5 0.6 0.5 1.2 0.409
Dose of dopamine (μg/kg/min) 10.9 8.2 8.8 6.3 0.295
Initial creatinine (mg/dL) 1.2 0.8 1.5 1.4 0.956
Initial urea (mg/dL) 93.8 68.9 82.9 59.0 0.475
ALT (UI/L) 174.7 171.0 209.5 776.3 0.355
Billirubine (mg/dL) 3.1 4.0 1.5 1.4 0.218
Initial platelet (inicial) 150.944 119.341 177.289 170.637 0.821
Platelet after 24 hours of CRRT 89.000 72.960 122.068 111.964 0.254
Platelet after 48 hours of CRRT 93.000 76.183 105.589 99.070 0.657
Maximum dose of heparin (UI/kg/h) 14.7 13.1 15.2 10.3 0.351
Ultrafiltration rate (mL/kg/h) 43.6 34.4 37.3 25.3 0.751
Circuit lifespan (h) 47.5 61.5 41.9 36.9 0.638
Bleeding Number % Bleeding Number %
Age <12 m >12 m
9 11.8 9 9.4 0.600
Sex Male Female
9 8.7 9 13 0.366
Weight <10 kg >10 kg
9 10 9 11 0.835
Diagnoses Cardiopathies Rest of diagnoses
10 10.5 8 10.4 0.977
Mechanical ventilation Yes NoCritical Care    Vol 13 No 6    Santiago et al.
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study, we did not record in which children the circuit was
primed with albumin and we cannot therefore analyze the effi-
cacy of this measure. Further studies are necessary to deter-
mine the efficacy of circuit-priming methods in the reduction of
hypotension at the time of connection.
The treatment of hypotension was different depending on the
situation of each patient. Generally, we used volume expan-
sion with colloids 10 to 20 ml/kg as the first measure. If the
hypotension was severe we also increased the vasoactive
drugs that the patient received, and when the haemoglobin
level was low we also transfused packed red cells.
Some authors have reported the onset of a bradykinin release
syndrome when using filters with the AN69 membrane primed
with blood; the syndrome presents as acute hypotension and
can be avoided by raising the pH [18]. Although we use AN69
17 11.7 1 3.7 0.211
Vasoactive drugs Yes No
15 11 3 8.3 0.638
Initial MAP < 55 mmHg > 55 mmHg
11 17.5 7 6.6 0.034
Initial hypotension Sí No
10 14.3 8 8.3 0.241
Dose of adrenaline >0.6 μg/kg/min >0.6 μg/kg/min
5 14.7 13 11 0.561
Platelet <50.000 >50.000
6 20 12 10.3 0.152
Platelet transfusion Sí No
14 18.9 4 4.1 0.002
CRRT technique Hemofiltration Hemodiafiltration
3 6.7 15 11.8 0.333
Filter surface <0.3 m2 >0.3 m2
9 14.3 9 14.7 0.937
Maximum dose of heparin >10 U/kg/h <10 U/kg/h
7 8.4 11 12.4 0.401
Mortality Yes No
10 55.6% 8 33.8% 0.068
ALT = alanine transferase; CRRT = continuous renal replacement therapy; MAP = mean arterial pressure; PELOD = pediatric logistic organ 
dysfunction; PIM = pediatric index of mortality; PRIMS = pediatric risk of mortality; SD = standard deviation.
Table 3 (Continued)
Risk factors of bleeding complications in children with CRRT
Figure 1
Evolution of sodium and chloride serum levels during the first 72 hours  of continuous renal replacement therapy Evolution of sodium and chloride serum levels during the first 72 hours 
of continuous renal replacement therapy.  Mean and standard deviation.Available online http://ccforum.com/content/13/6/R184
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membranes, we have not had this complication because we
do not prime the circuit with blood.
Hypotension can also occur if excessive ultrafiltration is pro-
grammed [5] or if the machine systems that measure the vol-
umes function incorrectly. To prevent this, both the fluid
balances measured by the CRRT machine and the clinical
state of the patient should be monitored continuously. Accord-
ing to our protocol, nurses measured hourly the input and out-
put fluid balance and checked the ultrafiltrate volume
registered by the machine. Furthermore a continuous clinical
vigilance was performed. According to these data the pro-
gramming of the ultrafiltration was changed by the intensivist.
We think that for this reason we have not found any complica-
tions of excessive ultrafiltration in our patients.
The need for anticoagulation of the CRRT system, associated
with the frequent alterations of coagulation that occur in these
patients, increases the risk of hemorrhage. Both CRRT and
heparin can produce a fall in the platelet count, as found in our
study, or an alteration of platelet function. Heparin continues
to be the most widely used method of anticoagulation in CRRT
[19], although it has been suggested that anticoagulation
using sodium citrate could reduce the risk of heparin-related
hemorrhage; however, sodium citrate increases the risk of
hypocalcemia and alkalosis [5,20].
Although premature coagulation of the CRRT filter is more
common in children [21], 10% of our patients presented clin-
ically significant hemorrhage, and there was a higher mortality
among these patients. In our study, we found no relationship
between the incidence of hemorrhage and the platelet counts
or doses of heparin used. However, an important limitation in
our study is that no analysis was performed of a possible rela-
tionship between hemorrhage and other disturbances of coag-
ulation. Moreover, it is also possible that patients with high risk
of haemorrhage received a low dose of heparin and this fact
could influence to not find relationship between heparin dose
and bleeding. Hemorrhage in critically ill patients on CRRT is
probably the consequence of several factors: a coagulation
disorder, altered tissue perfusion caused by the underlying
disease, and the alterations of coagulation caused by the
extracorporeal circuit and anticoagulation [8,22].
Electrolyte disturbances are very common in critically ill chil-
dren [23]. CRRT can be used to correct severe electrolyte dis-
turbances, but can also produce them [24]. The risk is higher
if inappropriate dialysis and/or replacement fluids are used
[25], as occurred in one of our patients [12]. In our study,
Figure 2
Evolution of potassium, calcium, phosphorus and magnesium serum  levels during the first 72 hours of continuous renal replacement therapy Evolution of potassium, calcium, phosphorus and magnesium serum 
levels during the first 72 hours of continuous renal replacement ther-
apy.  Mean and standard deviation.
Figure 3
Percentage of patients with high serum levels of electrolytes during the  first 72 hours of continuous renal replacement therapy Percentage of patients with high serum levels of electrolytes during the 
first 72 hours of continuous renal replacement therapy.  Mean and 
standard deviation.
Figure 4
Percentage of patients with low serum levels of electrolytes during the  first 72 hours of continuous renal replacement therapy Percentage of patients with low serum levels of electrolytes during the 
first 72 hours of continuous renal replacement therapy. Mean and 
standard deviation.Critical Care    Vol 13 No 6    Santiago et al.
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despite using balanced solutions, there was a significant fall in
the levels of sodium, chloride, and phosphate, leading to the
need to increase the concentration of these electrolytes in the
dialysis and replacement fluids or to administer intravenous
supplements. When balanced solutions are used high dose of
dialysis and/or replacement fluids should not produce more
electrolytes disorders. However we have not analyzed if elec-
trolytes disorders were associated to the intensity of fluid dose
prescriptions. Hyponatremia may develop if the dialysis and
replacement fluids do not compensate the negative sodium
balance [8]. In a previous study we found a very high incidence
of hypophosphatemia in children on CRRT; this was due to the
high efficacy of these techniques and the fact that the usual
replacement and dialysis fluids do not contain phosphate [26].
The addition of phosphates to replacement and dialysis fluids
did not cause any instability of the solutions or other complica-
tions, and reduced the incidence of hypophosphatemia and
the need for intravenous phosphate supplements [26]. There-
fore, as electrolyte disturbances are common in children on
CRRT, periodic controls of their blood levels should be per-
formed and the concentration in the replacement and dialysis
fluids should be monitored closely in order to detect errors in
the preparation of the fluids.
Other complications have been reported in patients on CRRT,
such as alkalosis secondary to the bicarbonate content of the
dialysis and replacement fluids [27], and errors of drug dose
[28]. These complications were not analyzed in our study.
Another limitation of our study is that we did not determine the
incidence of hypothermia, which is more common in children
on CRRT due to extracorporeal radiant heat exchange, or cath-
eter-related infection [8].
Conclusions
We conclude that the frequency of complications in children
on CRRT is high, and some of these complications can be
serious. The most common are hypotension at the time of con-
nection and electrolyte disturbances. The hemodynamic state
of children on CRRT should therefore be monitored closely
and frequent controls of the electrolyte concentrations should
be performed.
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